CNIPA.AI
专利申请人记载

APPLICANTS

原始名称记载: Beijing Yingu Medicine Sci Techno Co., Ltd.

浏览来源中的申请人名称,以及导入专利中保留的原始名称字段。

这里按名称检索,不代表已核验的法律主体。同名可能指不同个人或组织;别名和历史名称不自动合并。

此页精确匹配完整原始名称字段。字段可能包含多个申请人或其他记载主体角色,名称边界和法律主体尚未核验;保留全部标点,不进行拆分。

1 条已索引专利记录

专利数量指本站收录的去重专利记录,不是该申请人的完整专利总量。联合名称字段不代表单一企业。

目前没有可核验的数据覆盖日期和最后导入时间。专利公开日期不等于导入日期。目录缓存可能使新导入记录延迟出现。

在本地原始申请人字段中搜索包含这段完整文字的记录,可能包括联合名单或更长名称;这不是精确主体检索。

按此申请人条件检索专利
№ US20260000654A1发明专利
审中

USE OF BENCYCLOQUIDIUM BROMIDE, ISOMER THEREOF AND DERIVATIVE THEREOF IN PREPARATION OF OPHTHALMIC FORMULATION

USE OF BENCYCLOQUIDIUM BROMIDE, ISOMER THEREOF AND DERIVATIVE THEREOF IN PREPARATION OF OPHTHALMIC FORMULATION

The present invention relates to the technical field of medicine, and in particular to a use of bencycloquidium bromide, an isomer thereof and a derivative thereof in the preparation of a drug for preventing or treating an ophthalmic disease. Moreover, the present invention provides an ophthalmic formulation using the bencycloquidium bromide, the isomer thereof and the derivative thereof as active ingredients. According to the present invention, by using the bencycloquidium bromide, the isomer thereof and the derivative thereof in eyes, it is discovered that the bencycloquidium bromide, the isomer thereof and the derivative thereof have an obvious inhibitory effect on changes in ocular axial length and diopter in the progression process of a myopic refractive error, and then it is discovered that the ophthalmic formulation using the bencycloquidium bromide, the isomer thereof and the derivative thereof as active ingredients has significant advantages in the prevention and treatment of ophthalmic diseases, especially in preventing myopia and slowing down the progression of myopia, etc.

❖Beijing Yingu Medicine Sci Techno Co., Ltd.Wenzhan YU; Yuanyuan PAN; Yanyan LI; Fengquan YUAN; Zihan LIU; Qingyuan NI; Ya ZHANG§ 5/13 权利要求A61K 31/439, A61K 9/, A61K 9/8 +810